US EditionPublished • loading... • Updated
Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 4,500 Shares of Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 4,500 Shares of Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 4,500 shares of the firm's stock in a transaction dated Tuesday, April 7th. The stock was sold at an average price of $65.11, for a total transaction of $292,995.00. Following the completion of the transaction, the executive vice president directly owned 153,902 shares in the company, valued at $10,020,559.22. This represents a 2.84% decrease in their position…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
